321 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2437

HARBIN GLORIA PHARMACEUTICALS
CN¥2.2618.9%0%CN¥5.1bn/aPE23.6xn/a0%

300630

Hainan Poly Pharm
CN¥11.3441.4%-47.7%CN¥5.1bn/aPS4xE100.2%0%

301080

AcrobiosystemsLtd
CN¥42.3027.3%-39.7%CN¥5.1bCN¥46.93PE42.7xE28.0%2.1%

301211

Hubei Biocause Heilen Pharmaceutical
CN¥17.3721.0%-24.7%CN¥5.0bn/aPE38xn/a2.8%

301393

Suzhou Highfine Biotech
CN¥46.3330.9%-37.9%CN¥5.0bn/aPE46.9xn/a0.5%

688566

Jiangsu Jibeier Pharmaceutical
CN¥24.6825.3%-18.4%CN¥4.9bn/aPE20.1xE21.3%2.1%

603718

Shanghai Hile Bio-Technology
CN¥7.4524.2%-30.8%CN¥4.9bn/aPS21.4xn/a0.4%

688621

Beijing Sun-Novo Pharmaceutical Research
CN¥43.5540.0%-32.0%CN¥4.9bn/aPE22.7xE28.1%0.4%

603566

Pulike Biological Engineering
CN¥14.1221.8%-33.7%CN¥4.9bCN¥16.24PE36.6xE27.8%5.7%

600488

Tianjin Tianyao Pharmaceuticals
CN¥4.4012.8%-14.6%CN¥4.8bn/aPE35.5xn/a2.0%

688202

Shanghai Medicilon
CN¥35.9842.0%-52.7%CN¥4.8bn/aPS4.7xE124.4%0%

600479

ZhuZhou QianJin PharmaceuticalLtd
CN¥11.2916.3%-0.4%CN¥4.8bn/aPE14.9xn/a3.1%

301333

R&G PharmaStudies
CN¥49.7125.5%-30.2%CN¥4.8bCN¥55.00PE35.3xE26.7%0.4%

2793

Luoxin Pharmaceuticals Group Stock
CN¥4.4519.6%-20.4%CN¥4.7bn/aPS2xn/a0%

688687

Beijing Kawin Technology Share-Holding
CN¥28.2134.8%15.8%CN¥4.7bCN¥35.56PE39.2xE30.3%0.9%

600351

Yabao Pharmaceutical Group
CN¥6.3816.8%-24.7%CN¥4.6bn/aPE21.7xn/a2.4%

688222

HitGen
CN¥11.5030.7%-27.2%CN¥4.6bCN¥11.80PE101.9xE20.1%0.4%

2393

Tianjin Lisheng PharmaceuticalLtd
CN¥17.6818.6%-0.6%CN¥4.5bn/aPE12.1xn/a2.4%

300158

Shanxi Zhendong PharmaceuticalLtd
CN¥4.4931.7%-27.0%CN¥4.5bn/aPS1.4xn/a0%

600628

Shanghai New World
CN¥6.9713.9%-6.4%CN¥4.5bn/aPE112.3xn/a0.4%

688710

Shanghai Innostar Biotechnology
CN¥31.9331.6%n/aCN¥4.5bn/aPE25.6xn/an/a

603387

Getein Biotech
CN¥8.8523.1%-21.1%CN¥4.5bn/aPE17.4xn/a2.0%

688799

Hunan Warrant PharmaceuticalLtd
CN¥47.8020.9%16.5%CN¥4.5bCN¥59.00PE21.2xS19.5%1.9%

301089

Tuoxin Pharmaceutical GroupLtd
CN¥34.8929.3%-35.9%CN¥4.4bn/aPS11.1xn/a0.7%
Page 8 of 14
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.